Welcome to our dedicated page for Healthstream news (Ticker: HSTM), a resource for investors and traders seeking the latest updates and insights on Healthstream stock.
HealthStream reports on healthcare technology platforms for clinical workforce solutions used by healthcare organizations, professionals, payers, nursing schools and students. Company news commonly covers financial results, earnings calls, dividend declarations, share repurchase authorizations and operating updates tied to its platform-delivered learning, clinical development, credentialing and scheduling applications.
Updates also include additions to HealthStream’s workforce ecosystem, such as the MissionCare Collective caregiver network and myCNAjobs.com career network, as well as Virsys12 and the V12 Enterprise Suite for provider onboarding, credentialing, data governance and network management. Partnership announcements and workforce-development initiatives reflect the company’s focus on healthcare staffing, training, engagement and retention.
HealthStream (NASDAQ:HSTM) has completed the acquisition of CloudCME, enhancing its position in healthcare continuing education. Initially investing in CloudCME in March 2019, HealthStream now fully owns the leading SaaS application designed for managing continuing medical education (CME). This strategic move adds essential capabilities to their service offerings, including a user-friendly portal for CME management. The acquisition cost approximately $4.08 million in cash and shares. HealthStream expects this integration to advance their growth and improve healthcare quality.
HealthStream (HSTM) reported Q1 2022 revenues of $65.4 million, up 3% from Q1 2021. Operating income rose 22% to $4.0 million, and net income climbed 26% to $2.9 million with EPS at $0.09. Adjusted EBITDA reached $14.0 million, a 3% increase. The company announced an expansion of its share repurchase program by $10 million, following a previous $20 million completion. Additionally, there was a management change with Michael Collier promoted to Executive Vice President of Corporate Strategy & Development.
HealthStream, Inc. (Nasdaq: HSTM) will hold a conference call on April 26, 2022, to discuss its first quarter financial results for the period ending March 31, 2022. The results will be released after market close on April 25, 2022. The call will start at 9:00 a.m. ET, and can be accessed by phone or through a live audio webcast. HealthStream provides workforce and provider solutions aimed at improving healthcare outcomes by developing healthcare organizations' workforce capabilities.
HealthStream (Nasdaq: HSTM) has expanded its share repurchase program, authorizing up to an additional $10 million for repurchasing outstanding shares. This follows the prior $20 million repurchased since the program's inception on November 30, 2021. Repurchases will be conducted based on market conditions and regulatory compliance, with a termination date set for March 13, 2023, or once the budget is depleted. The program aims to enhance shareholder value through increased earnings per share.
HealthStream, Inc. (Nasdaq: HSTM) reported its financial results for Q4 and full year 2021. Fourth quarter revenues increased by 4% to $64.3 million, while operating loss was $0.5 million. For the year, revenues rose 5% to $256.7 million, but operating income decreased by 49% to $8.1 million. The CEO contributed $2.4 million in stock for employee shares, impacting net loss negatively. Adjusted EBITDA for Q4 was $12.0 million, up 12%. The company authorized a $20 million share repurchase program and acquired Rievent Technologies for $4 million. Full-year guidance for 2022 is $267.5 to $273.0 million in revenue.
HealthStream (Nasdaq: HSTM) has announced a conference call scheduled for February 22, 2022, to discuss its fourth quarter 2021 financial results. The results will be released post-market on February 21, 2022. Investors can participate by calling 877-647-2842 (U.S.) or 914-495-8564 (international) at 9:00 a.m. Eastern Time. A live audio webcast will also be available at their investor relations site. HealthStream focuses on workforce solutions to improve patient outcomes, providing services across the U.S. healthcare sector.
HealthStream (Nasdaq: HSTM) has appointed Terry Allison Rappuhn to its Board of Directors, effective immediately. Rappuhn will also serve on the Audit Committee. She brings extensive experience from her roles on six public company boards, focusing on healthcare providers, with a strong background in finance and cybersecurity governance. Rappuhn’s previous positions include serving as Chief Financial Officer at Quorum Health Group and a Certified Public Accountant at Ernst & Young. Her expertise is expected to enhance HealthStream’s financial oversight and governance.
HealthStream (NASDAQ: HSTM) has announced a significant stock contribution from CEO Robert A. Frist, Jr., amounting to approximately $2.25 million worth of shares. Frist donated 86,494 shares to benefit over 1,000 employees who have not previously participated in equity programs. This grant, effective immediately, will incur a compensation expense of about $2.25 million and an additional $185,000 for related administrative costs, impacting the company’s Q4 2021 financials. Importantly, this transaction will not dilute existing shareholders' shares, except Mr. Frist's.
HealthStream (NASDAQ: HSTM) has acquired substantially all assets of Rievent Technologies for approximately $4 million in cash. This acquisition enhances HealthStream's platform with a SaaS-based continuing education management application, Rievent™, which simplifies the processes for healthcare professionals to maintain licensing requirements. Rievent is recognized for its user-friendly interface and management tools, aiming to improve CME/CE delivery.
The integration of Rievent into the hStream platform is expected to enhance data utilization across applications, benefiting users.
HealthStream (Nasdaq: HSTM) has announced a new share repurchase program, allowing for the buyback of up to $20 million of its outstanding common stock. This initiative aims to enhance shareholder value by potentially increasing earnings per share (EPS). Repurchases will be conducted in the open market, following specific regulations, and may be influenced by market conditions. The program will terminate on November 29, 2022, or when the allocated funds are fully utilized. The plan does not obligate the company to purchase any specific number of shares.